ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103. A total of 13 filers reported holding ANEBULO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 5,066,290 | $15,477,516 | 11.03% |
| LVW Advisors, LLC | 672,331 | $2,053,972 | 0.42% |
| Praetorian PR LLC | 177,292 | $541,627 | 0.28% |
| Nantahala Capital Management | 511,073 | $1,561,328 | 0.13% |
| MANGROVE PARTNERS IM, LLC | 399,219 | $1,219,614 | 0.09% |
| Ikarian Capital, LLC | 157,862 | $503,580 | 0.06% |
| Tower Research Capital LLC (TRC) | 20,851 | $63,700 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,978 | $57,978 | 0.00% |
| ROYAL BANK OF CANADA | 48 | $0 | 0.00% |
| VANGUARD GROUP INC | 22,344 | $68,261 | 0.00% |
| WELLS FARGO & COMPANY/MN | 58 | $177 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| BlackRock Inc. | 4,193 | $12,809 | 0.00% |
External links
This page lists ANEBULO PHARMACEUTICALS INC's shareholders in Q3 2023. To view ANEBULO PHARMACEUTICALS INC's shareholder history, click here.